Kathleen Goetz - 16 May 2025 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Kathleen Goetz
Issuer symbol
AUPH
Transactions as of
16 May 2025
Net transactions value
$0
Form type
4
Filing time
16 May 2025, 17:04:45 UTC
Previous filing
16 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Goetz Kathleen Director #140, 14315-118 AVENUE, EDMONTON, ALBERTA, CANADA /s/ Kathleen Goetz 16 May 2025 0001896369

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Director Stock Option (right to buy) Award $0 +63,724 $0.000000 63,724 16 May 2025 Common Shares 63,724 $8.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest one year from date of grant.